← Back to all trials
Active Not Recruiting
NCT07023081
A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
Conditions: Pneumococcal Disease
Sex: All
Ages: 42 Days – 49 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 200
Sponsor: Pfizer
Location: Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning Guangxi
Summary
The purpose of this study is to learn about the safety of the 20-valent pneumococcal conjugate vaccine (20vPnC) among adults, children, and infants, as well as the immunogenicity of 20vPnC among infants and children under 2 years of age in China. This vaccine will be given as per the age-specific dosing schedules among healthy adults, children and infants in China.
This study is seeking healthy participants of 6 groups:
* Group 1: Adults ≥18 to \
Eligibility Criteria
Key inclusion criteria:
* Male or female participants:
* Adults ≥18 to \
Source: ClinicalTrials.gov (NCT07023081). StuddyBuddy aggregates publicly available trial information.
